| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2001 | US6287591 Stable for theraputic use, hiv, cytomegalo virus, antiinflammatory, antitumor |
| 09/11/2001 | US6287587 Forming a water in oil emulsion comprising a solution containing a water-soluble 2-piprazinone-1-acetic acid derivative and arganine as intergrin antagonist, a solvent, abiodegradable polymer, and fat and oil, removing the solvent |
| 09/11/2001 | US6287586 Pharmaceutical compositions of vanadium biguanide complexes and their use |
| 09/11/2001 | US6287585 Microbiocides |
| 09/11/2001 | US6287583 Low-pH, acid-containing personal care compositions which exhibit reduced sting |
| 09/11/2001 | US6287579 Oxidatively stable long-chain ethyl ester emollients |
| 09/11/2001 | US6287572 Genetic engineering |
| 09/11/2001 | US6287554 Chicken interleukin-15 and uses thereof |
| 09/11/2001 | US6287553 Skin care composition |
| 09/11/2001 | US6287549 Method for removing superfluous hairs |
| 09/11/2001 | US6287541 Oral care compositions |
| 09/11/2001 | US6287540 Therapeutic dry powder |
| 09/11/2001 | US6287285 Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device |
| 09/11/2001 | US6286513 Methods for treating superficial bladder carcinoma |
| 09/11/2001 | CA2230936C 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/11/2001 | CA2217171C New process for preparing (-)-trans-n-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-¢¢3,4-(methylenedioxy)phenoxy!methyl!-piperidine |
| 09/11/2001 | CA2209422C 4-amino-3-acylnaphthyridine derivatives |
| 09/11/2001 | CA2200742C Quinoxaline derivatives useful in therapy |
| 09/11/2001 | CA2195119C Formulations and methods for providing prolonged local anesthesia |
| 09/11/2001 | CA2176205C Osteogenic product and process |
| 09/11/2001 | CA2166889C Oligonucleotides with activity against human immunodeficiency virus |
| 09/11/2001 | CA2115426C Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 09/11/2001 | CA2087091C Excitatory amino acid antagonists |
| 09/11/2001 | CA2067187C Central nervous system activator and taste enhancing food additive |
| 09/11/2001 | CA2057578C 1,4-disubstituted piperazines, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2001 | CA2037099C Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz ¢cd! indole |
| 09/11/2001 | CA2031570C Substituted cyclohexenes as central nervous system agents |
| 09/11/2001 | CA2020368C Angiographic adjuvant |
| 09/11/2001 | CA2018824C Use of kojic acid for treating pigmentation diseases |
| 09/09/2001 | CA2575854A1 Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 09/09/2001 | CA2300246A1 Local delivery of 17-beta estradiol decreases neointimal hyperplasia following coronary angioplasty in porcine model |
| 09/07/2001 | WO2001064949A2 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | WO2001064937A2 Caspase-inhibitory-factor (cif) and uses thereof |
| 09/07/2001 | WO2001064899A2 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064877A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064756A1 Salmon-origin chondroitin sulfate |
| 09/07/2001 | WO2001064755A2 Isoxazole gegen virale erkrankungen |
| 09/07/2001 | WO2001064741A2 Methods for selectively modulating survivin apoptosis pathways |
| 09/07/2001 | WO2001064739A1 Tcf responsive element |
| 09/07/2001 | WO2001064737A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/07/2001 | WO2001064706A1 Antisense modulation of e2f transcription factor 1 expression |
| 09/07/2001 | WO2001064700A1 Novel macrolide compound jk |
| 09/07/2001 | WO2001064696A1 Dicarboxylato diammine platinum derivatives and compositions comprising them as anti-tumor agents |
| 09/07/2001 | WO2001064693A1 Phosphonate nucleotide compound |
| 09/07/2001 | WO2001064692A1 Cardioprotective phosphonates and malonates |
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064690A1 Gastro-specific prodrugs |
| 09/07/2001 | WO2001064687A1 Anti-infective ecta?tm¿ |
| 09/07/2001 | WO2001064685A2 Thienopyridine derivatives and their use as anti-inflammatory agents |
| 09/07/2001 | WO2001064682A1 Novel compound having antimalarial activity |
| 09/07/2001 | WO2001064681A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064678A2 Inhibitors of hepatitis c virus ns3 protease |
| 09/07/2001 | WO2001064677A1 Novel imidazotriazinones and the use thereof |
| 09/07/2001 | WO2001064676A2 INHIBITORS OF p38-α KINASE |
| 09/07/2001 | WO2001064674A1 2,4-disubstituted thiazolyl derivatives |
| 09/07/2001 | WO2001064673A1 Flavone derivatives, preparation method and use as medicines |
| 09/07/2001 | WO2001064672A1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs |
| 09/07/2001 | WO2001064670A1 Novel cyclic amide derivatives |
| 09/07/2001 | WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | WO2001064668A2 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors |
| 09/07/2001 | WO2001064666A1 Oxygen-containing heterocyclic compounds |
| 09/07/2001 | WO2001064665A1 Chroman derivatives as estrogenic compounds |
| 09/07/2001 | WO2001064663A2 Biologically active analogs of discodermolide |
| 09/07/2001 | WO2001064662A1 Allomorph isomer z hydrochloride of ranitidine |
| 09/07/2001 | WO2001064661A1 Antioxidants |
| 09/07/2001 | WO2001064660A1 Novel quinoline ligands and metal complexes for diagnosis and therapy |
| 09/07/2001 | WO2001064659A2 Indane derivatives and their use as cell adhesion inhibitors |
| 09/07/2001 | WO2001064656A1 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/07/2001 | WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/07/2001 | WO2001064654A1 Pyrimidine compounds |
| 09/07/2001 | WO2001064653A1 Pyrimidine compounds |
| 09/07/2001 | WO2001064650A2 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 09/07/2001 | WO2001064645A2 Derivatives of quinoline as alpha-2 antagonists |
| 09/07/2001 | WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 09/07/2001 | WO2001064642A2 Benzamides and related inhibitors of factor xa |
| 09/07/2001 | WO2001064639A2 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 09/07/2001 | WO2001064637A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 09/07/2001 | WO2001064635A1 Ningalin b analogs employable for reversing multidrug resistance |
| 09/07/2001 | WO2001064634A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 09/07/2001 | WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 09/07/2001 | WO2001064632A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/07/2001 | WO2001064254A2 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 09/07/2001 | WO2001064253A1 P-glycoprotein modifier-containing medicinal compositions to be delivered to the large intestine |
| 09/07/2001 | WO2001064252A2 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
| 09/07/2001 | WO2001064251A2 Combination chemotherapy |
| 09/07/2001 | WO2001064250A1 Remedies for malignant tumor-concomitant neurosis and azoor or analogous diseases thereof |
| 09/07/2001 | WO2001064247A2 Method of treating cancer with anti-neurotrophin agents |
| 09/07/2001 | WO2001064246A2 Farnesyl protein transferase inhibitor combinations with an her2 antibody |
| 09/07/2001 | WO2001064245A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | WO2001064238A2 Methods and compositions for regulating adipocytes |
| 09/07/2001 | WO2001064236A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 09/07/2001 | WO2001064231A1 Use of a composition |
| 09/07/2001 | WO2001064230A1 Use of catechin for preventing or treating coronary restenosis |
| 09/07/2001 | WO2001064226A2 Farnesyl protein transferase inhibitor combinations with platinum compounds |
| 09/07/2001 | WO2001064225A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 09/07/2001 | WO2001064223A1 Method for treating or preventing depression |
| 09/07/2001 | WO2001064222A1 Veterinary compositions for the treatment of parasitic diseases |